Investment Fund

122 Total Holdings:
As of 3/31/24
All Holdings: 1 - 15 of 122
Security Name Asset Type Shares or
Principal Amount
Market Value Percent of
Net Assets
descending arrow
Capital Group Central Cash Fund Short Term 1,266,035 $126,552,845.00 6.26%
Novo Nordisk AS, Class B Equity 629,450 $80,235,221.00 3.97%
Safran SA Equity 260,260 $58,978,154.00 2.92%
ASML Holding NV Equity 60,119 $57,867,541.00 2.86%
SAP SE Equity 289,144 $56,293,234.00 2.78%
TotalEnergies SE Equity 744,448 $50,975,786.00 2.52%
AstraZeneca PLC Equity 322,144 $43,416,112.00 2.15%
London Stock Exchange Group PLC Equity 348,689 $41,765,283.00 2.07%
Taiwan Semiconductor Manufacturing Co., Ltd. (ADR) Equity 281,420 $38,287,191.00 1.89%
L'Oreal SA, non-registered shares Equity 75,293 $35,631,475.00 1.76%
Airbus SE, non-registered shares Equity 189,688 $34,936,977.00 1.73%
Nestle SA Equity 323,819 $34,380,073.00 1.7%
Keyence Corp. Equity 72,720 $33,669,869.00 1.67%
EssilorLuxottica SA Equity 141,594 $32,033,497.00 1.58%
Sika AG Equity 106,599 $31,748,618.00 1.57%
All Holdings: 1 - 15 of 122